M&A activity in the healthcare industry is expected to remain robust over the next year. As a result, it is important to be able to navigate the complex issues that may arise in healthcare transactions. One of the primary issues that is critical to understand are the various types of intangible assets and the nuances of how they are valued for healthcare transaction negotiations. Learn more in this article by Tami Bolder.
This article was originally published in the Cleveland Bar Journal
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Date: July 30, 2018
Source: CBIZ
